Michael Altman
Co-Chair, Co-Founder, CEO

Michael spent the first part of his career on Wall Street as an equities trader. After 9/11, he decided to make a life change and went into pharmacy, his family business. As an integrative pharmacist with a passion for health and wellness, he purchased Greenleaf Pharmacy in Westchester, NY and quickly transformed it from an ordinary drugstore into an extraordinary business, subsequently selling it for nearly triple the price in a declining industry. 

Since then, Michael has been consulting for a variety of businesses that include both start-ups in integrative health, wellness and alternative medicine as well as international corporations in the transportation and tourism industries. Michael’s unique expertise enables him to lead on two ends of the spectrum taking startups from concept to profitability, and also recovering and expanding failing global companies. Most recently, Michael was recruited by RATP, the fourth largest transportation company in the world as the CEO of Open Loop New York, their U.S. tourism division. After a complete restructuring, the company’s revenue increased by 100% by end of year one.

Michael is a graduate of Northeastern University School Of Pharmacy and Allied Health, where he received a Bachelor’s Degree in Pharmacy.

David Weinstein, M.D., Ph.D.
Co-Chair, Co-Founder, CMO and CSO

David is long practicing neuroscientist, he resigned his full time academic position as a Professor in the Departments of Neuroscience, Neurology, Pathology and the Comprehensive Cancer Center at the Albert Einstein College of Medicine, to start GliaMed,Inc., a biotechnology company founded on discoveries in regenerative medicine made in his laboratory. Over the ten-plus years at GliaMed, he served at various times as the Chief Executive, Chief Scientific and Chief Medical Officer, leading GliaMed’s drug discovery and development efforts.

David is an internationally recognized expert in the areas of Multiple Sclerosis, brain tumor research, and spinal cord and nerve injury and regeneration. He has served as a consultant to the National Institutes of Health and the World Health Organization and is an external advisor and consultant for numerous scientific research organizations, including the Children’s Brain Tumor Foundation, the National Institutes of Health, the Christopher Reeves Paralysis Foundation, the Paralyzed Veterans of America/Spinal Cord Research Foundation and the National Multiple Sclerosis Foundation. In addition to his MD and PhD degrees, David also holds an MS in Pharmacology from New York University College of Medicine. Dr. Weinstein has been a consultant to numerous venture capital firms, and is the inventor on several patents in the areas of tissue regeneration, neurology, neuropathology and viral diagnostics.

Board of Directors

Michael Altman
Co-Chair, Co-Founder, CEO Rivertown Therapeutics, Inc.

David Weinstein, M.D., Ph.D.
Co-Chair, Co-Founder, CMO and CSO Rivertown Therapeutics, Inc.

Imran Karim

Scientific Advisory Board

Elaine Fuchs, Ph.D.
Investigator, Howard Hughes Medical Institute
Rebecca C. Lancefield Professor; Robin Chemers Neustein Laboratory of Mammalian Cell Biology and Development, Rockefeller University

Maria Hordinsky, M.D.
Professor and Chair, Department of Dermatology, University of Minnesota School of Medicine

Danielle Engler, M.D.
Former Vice Chair and Professor, Department of Dermatology, Columbia College of Physicians and Surgeons